Tag: HVAD
Targeted blood pressure management helps to reduce strokes in patients with HVAD
An analysis on the impact of stroke severity in patients receiving the HeartWare HVAD system (Me...
HeartWare HVAD system receives US FDA approval
Medtronic has received United States Food and Drug Administration (FDA) approval for a less-invasi...
US FDA classifies HeartWare HVAD power issues as a Class I recall
The US FDA has classified Medtronic’s recent voluntary urgent field action related to the HeartW...
Medtronic HeartWare HVAD approved for destination therapy
The US Food and Drug Administration (FDA) has approved Medtronic’s HeartWare HVAD system as a de...
US FDA designates Medtronic HVAD system controller field action as class I recall
The US Food and Drug Administration (FDA) has classified Medtronic’s recently initiated voluntar...
LATERAL study offers positive overall results for Medtronic HVAD
Preliminary results from the Medtronic -sponsored HVAD LATERAL study have demonstrated overall p...
Medtronic ENDURANCE Supplemental trial of HVAD fails to meet primary endpoint
Medtronic’s ENDURANCE Supplemental trial of the company’s HVAD ventricular assist device has fai...
Medtronic first to receive CE mark for less-invasive HVAD implant procedure
Medtronic’s HVAD system left ventricular assist device (LVAD) has received the CE mark for a les...
FDA deems two HeartWare HVAD recalls as “Class I”
Medtronic has reported that two previously communicated global voluntary recalls related to the ...
Purchase of HeartWare by Medtronic completed
Medtronic has completed its acquisition of HeartWare International—a developer of less-invasive,...
